Merck Gross Profit 2010-2024 | MKKGY
Merck annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Merck gross profit for the quarter ending June 30, 2024 was $3.482B, a 0.95% increase year-over-year.
- Merck gross profit for the twelve months ending June 30, 2024 was $13.149B, a 7.19% decline year-over-year.
- Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
- Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
- Merck annual gross profit for 2021 was $14.595B, a 19.42% increase from 2020.
Merck Annual Gross Profit
(Millions of US $) |
| 2023 |
$13,413 |
| 2022 |
$14,440 |
| 2021 |
$14,595 |
| 2020 |
$12,221 |
| 2019 |
$11,364 |
| 2018 |
$11,165 |
| 2017 |
$11,311 |
| 2016 |
$10,870 |
| 2015 |
$9,730 |
| 2014 |
$10,600 |
| 2013 |
$10,763 |
| 2012 |
$10,308 |
| 2011 |
$9,915 |
| 2010 |
$12,338 |
| 2009 |
$10,807 |
Merck Quarterly Gross Profit
(Millions of US $) |
| 2024-06-30 |
$3,482 |
| 2024-03-31 |
$3,267 |
| 2023-12-31 |
$3,123 |
| 2023-09-30 |
$3,277 |
| 2023-06-30 |
$3,449 |
| 2023-03-31 |
$3,564 |
| 2022-12-31 |
$3,470 |
| 2022-09-30 |
$3,685 |
| 2022-06-30 |
$3,681 |
| 2022-03-31 |
$3,603 |
| 2021-12-31 |
$3,731 |
| 2021-09-30 |
$3,672 |
| 2021-06-30 |
$3,683 |
| 2021-03-31 |
$3,508 |
| 2020-12-31 |
$3,340 |
| 2020-09-30 |
$3,122 |
| 2020-06-30 |
$2,763 |
| 2020-03-31 |
$2,996 |
| 2019-12-31 |
$2,987 |
| 2019-09-30 |
$2,865 |
| 2019-06-30 |
$2,829 |
| 2019-03-31 |
$2,683 |
| 2018-12-31 |
$2,601 |
| 2018-09-30 |
$2,796 |
| 2018-06-30 |
$2,854 |
| 2018-03-31 |
$2,914 |
| 2017-12-31 |
$2,908 |
| 2017-09-30 |
$2,854 |
| 2017-06-30 |
$2,816 |
| 2017-03-31 |
$2,734 |
| 2016-12-31 |
$2,696 |
| 2016-09-30 |
$2,760 |
| 2016-06-30 |
$2,813 |
| 2016-03-31 |
$2,601 |
| 2015-12-31 |
$2,537 |
| 2015-09-30 |
$2,444 |
| 2015-06-30 |
$2,437 |
| 2015-03-31 |
$2,366 |
| 2014-12-31 |
$2,114 |
| 2014-09-30 |
$2,638 |
| 2014-06-30 |
$2,690 |
| 2014-03-31 |
$2,644 |
| 2013-12-31 |
$2,672 |
| 2013-09-30 |
$2,687 |
| 2013-06-30 |
$2,767 |
| 2013-03-31 |
$2,625 |
| 2012-12-31 |
$3,646 |
| 2012-09-30 |
$2,570 |
| 2012-06-30 |
$2,482 |
| 2012-03-31 |
$3,274 |
| 2011-12-31 |
$3,311 |
| 2011-09-30 |
$3,585 |
| 2011-06-30 |
$2,583 |
| 2011-03-31 |
$3,505 |
| 2010-12-31 |
$3,707 |
| 2010-09-30 |
$2,345 |
| 2010-06-30 |
$2,695 |
| 2010-03-31 |
$2,791 |
| 2009-12-31 |
$2,983 |
| 2009-09-30 |
$2,778 |
| 2009-06-30 |
$2,590 |
| 2009-03-31 |
$2,456 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
